About Us 關於我們

---

TSCT focuses on Adipose Derived Stem Cell (ADSC) stem cell treatments for neurological disorders such as stroke, Parkinson's Disease, Alzheimer's and Multiple Sclerosis.  Though we also offer stem cell treatments for other applications, our research and our expertise is focused on degenerative neurological disorders.  Cells are prepared and processed in a Good Tissue Practice (GTP) certified lab.  

We also offer the application of a proprietary stem cell culture, developed by our research partners, to improve the efficacy of our stem cell treatments.  This culture improves cell prime state, reduces cell inflammation, improves cell growth - amongst other benefits - all of which help in improving on the efficacy of our stem cell treatments. 

Treatment programs vary based on individual case.  Though we are expanding our network of partner clinics regionally to allow for local treatments, we currently recommend that patients conduct their treatments in Taiwan.  

TSCT 專注於脂肪來源幹細胞 (ADSC) 幹細胞治療中風、帕金森氏病、阿爾茨海默氏症和多發性硬化症等神經系統疾病。雖然我們也為其他應用提供幹細胞治療，但我們的研究和專業知識主要集中在退行性神經系統疾病上。細胞在Good Tissue Practice (GTP) 認證的實驗室中製備和處理。

我們還提供由我們的研究合作夥伴開發的專有乾細胞培養物的應用，以提高我們幹細胞治療的功效。這種培養物可改善細胞初始狀態、減少細胞炎症、促進細胞生長 - 除其他好處外 - 所有這些都有助於提高我們幹細胞治療的功效。

治療方案因個案而異。雖然我們正在擴大區域合作診所網絡以允許在當地進行治療，但我們目前建議患者在台灣進行治療。